These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 29850358)
1. Increasing the Interval of Canakinumab Administration Effectively Supports the Remission of Schnitzler's Syndrome. Gorodetskiy VR; Salugina SO; Fedorov ES Case Rep Rheumatol; 2018; 2018():5416907. PubMed ID: 29850358 [TBL] [Abstract][Full Text] [Related]
2. A case of Schnitzler's syndrome without monoclonal gammopathy successfully treated with canakinumab. Fujita Y; Asano T; Sakai A; Norikawa N; Yamamoto T; Matsumoto H; Sato S; Temmoku J; Yashiro-Furuya M; Matsuoka N; Watanabe H; Migita K BMC Musculoskelet Disord; 2021 Mar; 22(1):257. PubMed ID: 33685423 [TBL] [Abstract][Full Text] [Related]
3. Sustained efficacy of the monoclonal anti-interleukin-1 beta antibody canakinumab in a 9-month trial in Schnitzler's syndrome. de Koning HD; Schalkwijk J; van der Ven-Jongekrijg J; Stoffels M; van der Meer JW; Simon A Ann Rheum Dis; 2013 Oct; 72(10):1634-8. PubMed ID: 23087179 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of interleukin-1 blockade in Schnitzler's syndrome without detectable monoclonal gammopathy: a case-based review. Bixio R; Rossini M; Giollo A Clin Rheumatol; 2021 Jul; 40(7):2973-2977. PubMed ID: 33175311 [TBL] [Abstract][Full Text] [Related]
5. Schnitzler's Syndrome-Diagnostic Experience, Approaches to Therapy, and Patient Management according to a Multicenter Russian Cohort. Salugina SO; Torgashina AV; Borzova EY; Rameev VV; Gorodetsky VR; Fedorov ES; Muravyova NV Dokl Biochem Biophys; 2024 Aug; 517(1):214-227. PubMed ID: 38861148 [TBL] [Abstract][Full Text] [Related]
6. The role of interleukin-1 beta in the pathophysiology of Schnitzler's syndrome. de Koning HD; Schalkwijk J; Stoffels M; Jongekrijg J; Jacobs JF; Verwiel E; Koenen HJ; Preijers F; Holzinger D; Joosten I; van der Meer JW; Simon A Arthritis Res Ther; 2015 Jul; 17(1):187. PubMed ID: 26198339 [TBL] [Abstract][Full Text] [Related]
7. Mast-cell interleukin-1β, neutrophil interleukin-17 and epidermal antimicrobial proteins in the neutrophilic urticarial dermatosis in Schnitzler's syndrome. de Koning HD; van Vlijmen-Willems IM; Rodijk-Olthuis D; van der Meer JW; Zeeuwen PL; Simon A; Schalkwijk J Br J Dermatol; 2015 Aug; 173(2):448-56. PubMed ID: 25904179 [TBL] [Abstract][Full Text] [Related]
8. Schnitzler syndrome refractory to anakinra: successful treatment with canakinumab. Salcedo-Mingoarranz AL; Dorado-Fernández M; García-Martínez S; Collado-Ramos P; Silvestre-Torner N J Dermatolog Treat; 2023 Dec; 34(1):2242705. PubMed ID: 37551725 [TBL] [Abstract][Full Text] [Related]
9. A Case of Schnitzler's Syndrome without Monoclonal Gammopathy-Associated Chronic Urticaria Treated with Anakinra. Ahn MJ; Yu JE; Jeong J; Sim DW; Koh YI Yonsei Med J; 2018 Jan; 59(1):154-157. PubMed ID: 29214791 [TBL] [Abstract][Full Text] [Related]
10. Schnitzler's Syndrome: A Diagnostic Consideration in Evaluating the Constellation of Monoclonal Gammopathy and Chronic Urticaria. Mamadgi J; Babar L; Bhagavatula R; Sadashiv S; Dantey K; Apostolova M J Hematol; 2021 Jun; 10(3):143-146. PubMed ID: 34267853 [TBL] [Abstract][Full Text] [Related]
11. Different Therapeutic Paths (Colchicine vs. Anakinra) in Two Patients With Schnitzler's Syndrome. Barešić M; Mitrović J; Morović Vergles J; Anić B Arch Rheumatol; 2016 Dec; 31(4):377-380. PubMed ID: 30375570 [TBL] [Abstract][Full Text] [Related]
12. Schnitzler's syndrome: diagnosis, treatment, and follow-up. Simon A; Asli B; Braun-Falco M; De Koning H; Fermand JP; Grattan C; Krause K; Lachmann H; Lenormand C; Martinez-Taboada V; Maurer M; Peters M; Rizzi R; Rongioletti F; Ruzicka T; Schnitzler L; Schubert B; Sibilia J; Lipsker D Allergy; 2013; 68(5):562-8. PubMed ID: 23480774 [TBL] [Abstract][Full Text] [Related]
13. Schnitzler's syndrome: lessons from 281 cases. de Koning HD Clin Transl Allergy; 2014; 4():41. PubMed ID: 25905009 [TBL] [Abstract][Full Text] [Related]
14. Skin and Systemic Inflammation in Schnitzler's Syndrome Are Associated With Neutrophil Extracellular Trap Formation. Bonnekoh H; Scheffel J; Wu J; Hoffmann S; Maurer M; Krause K Front Immunol; 2019; 10():546. PubMed ID: 30967871 [TBL] [Abstract][Full Text] [Related]
15. Schnitzler's syndrome - a novel hypothesis of a shared pathophysiologic mechanism with Waldenström's disease. van Leersum FS; Potjewijd J; van Geel M; Steijlen PM; Vreeburg M Orphanet J Rare Dis; 2019 Jun; 14(1):151. PubMed ID: 31228950 [TBL] [Abstract][Full Text] [Related]
16. Beneficial response to anakinra and thalidomide in Schnitzler's syndrome. de Koning HD; Bodar EJ; Simon A; van der Hilst JC; Netea MG; van der Meer JW Ann Rheum Dis; 2006 Apr; 65(4):542-4. PubMed ID: 16096327 [TBL] [Abstract][Full Text] [Related]
19. A Chinese case series of Schnitzler syndrome and complete remission in one tocilizumab-treated patient. Yan R; Cao W; Liu X; Li F; Shen M Clin Rheumatol; 2020 Dec; 39(12):3847-3852. PubMed ID: 32519052 [TBL] [Abstract][Full Text] [Related]